Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by KBC Group NV

KBC Group NV lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 65.6% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 424,739 shares of the medical equipment provider's stock after buying an additional 168,210 shares during the period. Intuitive Surgical comprises 0.6% of KBC Group NV's investment portfolio, making the stock its 21st biggest holding. KBC Group NV owned approximately 0.12% of Intuitive Surgical worth $208,661,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of the business. Mirador Capital Partners LP grew its position in Intuitive Surgical by 1.4% during the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider's stock worth $1,732,000 after buying an additional 50 shares during the period. Advisors Asset Management Inc. increased its stake in Intuitive Surgical by 18.1% in the 1st quarter. Advisors Asset Management Inc. now owns 7,380 shares of the medical equipment provider's stock valued at $2,945,000 after purchasing an additional 1,129 shares in the last quarter. Consolidated Planning Corp raised its holdings in Intuitive Surgical by 17.4% during the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider's stock worth $3,979,000 after purchasing an additional 1,198 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund boosted its position in Intuitive Surgical by 617.1% during the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider's stock worth $39,622,000 after purchasing an additional 76,649 shares in the last quarter. Finally, Brookstone Capital Management grew its holdings in Intuitive Surgical by 22.4% in the second quarter. Brookstone Capital Management now owns 12,530 shares of the medical equipment provider's stock valued at $5,340,000 after purchasing an additional 2,289 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Up 0.9 %

Shares of ISRG stock traded up $4.58 on Thursday, reaching $541.27. 716,610 shares of the stock were exchanged, compared to its average volume of 1,455,953. Intuitive Surgical, Inc. has a 1-year low of $291.39 and a 1-year high of $544.38. The stock has a market cap of $192.79 billion, a P/E ratio of 86.28, a price-to-earnings-growth ratio of 5.28 and a beta of 1.39. The firm has a 50 day moving average of $496.95 and a two-hundred day moving average of $455.65.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Analyst Ratings Changes

ISRG has been the subject of several research reports. BTIG Research set a $535.00 price target on Intuitive Surgical in a research note on Friday, October 18th. Evercore ISI restated a "cautious" rating on shares of Intuitive Surgical in a research report on Friday, October 18th. JPMorgan Chase & Co. increased their price target on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an "overweight" rating in a research report on Friday, October 11th. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a research report on Friday, October 18th. Finally, Piper Sandler reiterated an "overweight" rating and set a $538.00 target price (up previously from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. One analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $513.74.

Insider Activity

In other Intuitive Surgical news, General Counsel Gary Loeb sold 300 shares of the business's stock in a transaction dated Monday, September 9th. The stock was sold at an average price of $475.00, for a total transaction of $142,500.00. Following the transaction, the general counsel now owns 1,595 shares in the company, valued at $757,625. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, General Counsel Gary Loeb sold 300 shares of Intuitive Surgical stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of $475.00, for a total transaction of $142,500.00. Following the sale, the general counsel now owns 1,595 shares in the company, valued at $757,625. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Jamie Samath sold 22,903 shares of the firm's stock in a transaction on Friday, November 8th. The shares were sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the sale, the insider now directly owns 8,757 shares of the company's stock, valued at approximately $4,597,425. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 91,178 shares of company stock valued at $45,897,071. Company insiders own 0.90% of the company's stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.